Latest news
BNGO: Record Q2 revenue and margin driven by clinical adoption, with growth limited by supply constraints - TradingViewTradingView · Mon, 10 Aug 2026 21:31:27 GMTBionano Reports Q2 2026 Revenue of $8.2M, Gross Margin 53% - TradingViewTradingView · Mon, 10 Aug 2026 20:14:34 GMTBionano Genomics, Inc. Q2 2026: Revenue $8.17M, EPS $(0.64) — 10-Q Summary - TradingViewTradingView · Mon, 10 Aug 2026 20:11:01 GMTBNGO: Q2 2026 revenue rose 21% year-over-year, with improved margins and all secured debt retired - TradingViewTradingView · Mon, 10 Aug 2026 20:10:02 GMTBNGO Q2'26 Earnings: EPS estimate is (0.67) USD - TradingViewTradingView · Fri, 07 Aug 2026 11:00:34 GMTBionano Genomics, Inc. Revenue Breakdown – NASDAQ:BNGO - TradingViewTradingView · Sat, 01 Aug 2026 02:59:40 GMT